2-substituted pyrimidines and their use as pesticides

Details for Australian Patent Application No. 2005245580 (hide)

Owner BASF Aktiengesellschaft

Inventors Schwogler, Anja; Muller, Bernd; Schieweck, Frank; Stierl, Reinhard; Strathmann, Siegfried; Gewehr, Markus; Hunger, Udo; Rheinheimer, Joachim; Scherer, Maria; Schafer, Peter; Grammenos, Wassilios; Wagner, Oliver; Blettner, Carsten; Grote, Thomas; Schofl, Ulrich

Agent Watermark

Pub. Number AU-A-2005245580

PCT Pub. Number WO2005/113538

Priority 102004025363.3 19.05.04 DE

Filing date 17 May 2005

Wipo publication date 1 December 2005

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A01N 43/54 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2005/113538 Priority application(s): WO2005/113538

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245592-Process for producing heterophasic alpha-olefin polymers

2005245572-Identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib